RENEE MONTAGNE, Host:
More documents pointing to shortcomings with Avandia emerged yesterday and these came from Glaxo, though the drugmaker didn't want the public to see them. NPR's Scott Hensley reports.
SCOTT HENSLEY: Scott Hensley, NPR News, Washington.
NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.